tACS for Sensory Motor Recovery After Stroke
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06029062 |
Recruitment Status :
Not yet recruiting
First Posted : September 8, 2023
Last Update Posted : May 8, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Motor Recovery | Device: tACS Sham Device: tACS 10Hz Device: tACS 20Hz | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 14 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | tACS Brain Neuromodulation for Sensory and Motor Recovery After Neurological Impairments |
Estimated Study Start Date : | September 1, 2024 |
Estimated Primary Completion Date : | September 30, 2027 |
Estimated Study Completion Date : | March 31, 2028 |
![](/ct2/html/images/NIH_NLM_ABRV_BLK_4.png)
Arm | Intervention/treatment |
---|---|
Experimental: tACS Sham, tACS 10Hz, tACS 20Hz
tACS Sham is a temporary non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp for up to 30 second, it is not designed to entrain neuronal activity into any external regulatory frequency patterns. tACS 10Hz is a 10Hz non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp or 20 or 40 minutes to entrain neuronal activity into 10Hz frequency patterns. tACS 20Hz is a 20Hz non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp for 20 or 40 minutes to entrain neuronal activity into 20Hz frequency patterns. |
Device: tACS Sham
Sham tACS will applied to the brain through the scalp for 20 minutes. Device: tACS 10Hz 10Hz tACS will applied to the brain through the scalp for 20 minutes. Device: tACS 20Hz 20Hz tACS will applied to the brain through the scalp for 20 minutes. |
Experimental: HD-tACS 20Hz, HD-tACS 10Hz, HD-tACS Sham
tACS Sham is a temporary non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp for up to 30 second, it is not designed to entrain neuronal activity into any external regulatory frequency patterns. tACS 10Hz is a 10Hz non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp or 20 or 40 minutes to entrain neuronal activity into 10Hz frequency patterns. tACS 20Hz is a 20Hz non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp for 20 or 40 minutes to entrain neuronal activity into 20Hz frequency patterns. |
Device: tACS Sham
Sham tACS will applied to the brain through the scalp for 20 minutes. Device: tACS 10Hz 10Hz tACS will applied to the brain through the scalp for 20 minutes. Device: tACS 20Hz 20Hz tACS will applied to the brain through the scalp for 20 minutes. |
Experimental: HD-tACS 10Hz, HD-tACS 20Hz, HD-tACS Sham
tACS Sham is a temporary non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp for up to 30 second, it is not designed to entrain neuronal activity into any external regulatory frequency patterns. tACS 10Hz is a 10Hz non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp or 20 or 40 minutes to entrain neuronal activity into 10Hz frequency patterns. tACS 20Hz is a 20Hz non-invasive electrical stimulation that applies a weak oscillatory current to the brain through the scalp for 20 or 40 minutes to entrain neuronal activity into 20Hz frequency patterns. |
Device: tACS Sham
Sham tACS will applied to the brain through the scalp for 20 minutes. Device: tACS 10Hz 10Hz tACS will applied to the brain through the scalp for 20 minutes. Device: tACS 20Hz 20Hz tACS will applied to the brain through the scalp for 20 minutes. |
- Block and Box Test (BBT) of Motor functional test [ Time Frame: Change of BBT performance 5 minutes before and 5 minutes after the tACS intervention will be measured. ]The Box and Block Test (BBT) measures unilateral gross manual dexterity. It is a quick and simple test used with a wide range of populations, including clients with stroke.
- EEG alpha band and Beta band [ Time Frame: Change of EEG alpha band and Beta band 5 minutes before and 5 minutes after the tACS intervention will be measured. ]Electroencephalography (EEG) is valuable to infer and evaluate the neural interaction. Components of the alpha and beta frequency bands like the sensorimotor rhythm originated from the primary motor cortex and related brain areas reflect human movement. The power of 8-13 Hz alpha and 14-30 Hz beta frequency bands will be used for the classification.
![](/ct2/html/images/NIH_NLM_ABRV_BLK_4.png)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion/exclusion criteria for stroke subjects
Inclusion criteria:
- Age between 18~75 years old
- ≥ 6 months post stroke, medically stable;
- Unilateral, single stroke (no restriction on type (ischemic or hemorrhagic) or volume (large or small) of stroke);
- Visible finger flexor activation/movement
- The ability to give consent
Exclusion criteria:
- Patients with visual deficit/neglect; hearing or cognitive impairment;
- Patients that are currently adjusting tone alternating medications (e.g., baclofen), or
- Patients received botulinum toxin injection to the arm/fingers <4 months, or phenol injections <2 years;
- Patients with pacemaker, metal implants or supplemental oxygen;
- Patients who have musculoskeletal disorders, including pain in the affected side
- Women who are pregnant.
![](/ct2/html/images/NIH_NLM_ABRV_BLK_4.png)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06029062
Contact: Sheng Li, MD, Ph.D | (713) 797-7125 | sheng.li@uth.tmc.edu | |
Contact: Shengai Li, MS | 713-797-7561 | shengai.li@uth.tmc.edu |
United States, Texas | |
The University of Texas Health Science Center | |
Houston, Texas, United States, 77030 | |
Contact: Sheng Li, MD, PhD 713-797-7125 sheng.li@uth.tmc.edu | |
Contact: Shengai Li, MS 713-797-7561 shengai.li@uth.tmc.edu |
Principal Investigator: | Sheng Li, MD, Ph.D | The University of Texas Health Science Center, Houston |
Responsible Party: | Sheng Li, Professor, The University of Texas Health Science Center, Houston |
ClinicalTrials.gov Identifier: | NCT06029062 |
Other Study ID Numbers: |
HSC-MS-22-0046 (Experiment 1) |
First Posted: | September 8, 2023 Key Record Dates |
Last Update Posted: | May 8, 2024 |
Last Verified: | May 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Device Product Not Approved or Cleared by U.S. FDA: | Yes |
Product Manufactured in and Exported from the U.S.: | No |
tACS Motor recovery |